DermAI to Evaluate Human Factor of Testing

Overview

About this study

The purpose of this study is to develop the performance characteristics and human factor considerations to support fully remote patch testing.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults over the age of 18.
  • Willing and able to provide informed consent.

Exclusion Criteria:

  • Under 18 years of age.
  • Has used topical or oral steroids two weeks prior to patch testing.
  • Currently taking immunosuppression agents or is immunocompromised due to medical condition.
  • No sunburn or rash at site of testing.
  • Women who are breastfeeding or pregnant.
  • Treatment with ultraviolet (UV) light (including tanning) during the two weeks prior to visit.
  • Subjects unable to comply with patch test study requirements including multiple return visits and activity restrictions (e.g., protecting patch test area from excess moisture due to showering).

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 2/1/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Matthew Hall, M.D.

Open for enrollment

Contact information:

Laura Pacheco-Spann M.S.

(904) 953-0408

FLAQHSCS@mayo.edu

More information

Publications

Publications are currently not available